CVS Continues Preferred Status For Harvoni Over Viekira Pak
With the release of its formulary exclusions for 2016, CVS Health continues to prefer Gilead's HCV treatment over AbbVie's; just last week, Express Scripts continued with the opposite.
With the release of its formulary exclusions for 2016, CVS Health continues to prefer Gilead's HCV treatment over AbbVie's; just last week, Express Scripts continued with the opposite.